Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Prina

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Antimicrobial Agents and Chemotherapy|February 24, 2016
From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial ActivityEmilie Durieu, Eric Prina, Olivier Leclercq, et al.
ACS Infectious Diseases|June 22, 2022
Effects of Structurally Different HDAC Inhibitors against <i>Trypanosoma cruzi</i>, <i>Leishmania</i>, and <i>Schistosoma mansoni</i>Elisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Molecular and Cellular Biology|December 17, 2004
Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell functionAdrien Kissenpfennig, Smina Aït-Yahia, Valérie Clair-Moninot, et al.
Cell Reports|May 9, 2024
Structural and mechanistic insights into the function of Leishmania ribosome lacking a single pseudouridine modificationK Shanmugha Rajan, Saurav Aryal, Disha-Gajanan Hiregange, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Antimicrobial Agents and Chemotherapy|February 24, 2016
From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial ActivityEmilie Durieu, Eric Prina, Olivier Leclercq, et al.
ACS Infectious Diseases|June 22, 2022
Effects of Structurally Different HDAC Inhibitors against <i>Trypanosoma cruzi</i>, <i>Leishmania</i>, and <i>Schistosoma mansoni</i>Elisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Molecular and Cellular Biology|December 17, 2004
Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell functionAdrien Kissenpfennig, Smina Aït-Yahia, Valérie Clair-Moninot, et al.
Cell Reports|May 9, 2024
Structural and mechanistic insights into the function of Leishmania ribosome lacking a single pseudouridine modificationK Shanmugha Rajan, Saurav Aryal, Disha-Gajanan Hiregange, et al.
Pageof 5